NAVA Unloading - Effects on Distribution of Ventilation
Acute Respiratory Failure
About this trial
This is an interventional supportive care trial for Acute Respiratory Failure focused on measuring Neurally adjusted ventilatory assist
Eligibility Criteria
Inclusion Criteria:
- Patients belonging to Neurosurgical ICU
- Intubated for ≥48h
- Weaning phase from Mechanical Ventilation
Exclusion Criteria:
- bleeding disorders (PK INR>1,5 or APTT>50s or platelet count <50000/µL) or
- unstable intracranial pressure (ICP>20 mmHg during the latest 8 hours) or
- unstable circulation (requiring high vasopressor dose, for example Noradrenalin >0,2µg/kg/min) or
- too severe lung disease (PFI ≤ 26,7 kPa or PEEP >10 cmH2O or FiO2>0,5 at study entry point) or
- fever> 38,5°C or
- tendency to hyperventilation (PaCO2 < 4,5 kPa at study entry point).
Sites / Locations
- Dept. Anesthesiology, Surgical Services and Intensive Care Medicine,Karolinska Univeristy HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Active Comparator
PScli1
NAVAcli
NAVA40%
NAVA60%
PScli2
Patients are ventilated in Pressure support (PS) according to the Clinical settings for 30min.
Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to match to respiratory muscle unloading reached with PScli1. Patients are ventilated in NAVAcli for 30min.
Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 40% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA40% for 30min.
Patients are ventilated in Neurally Adjusted Ventilatory Assist (NAVA) and the assist is set in order to target 60% muscle unloading based on the Neuro-Ventilatory Efficiency (NVE) measurement. Patients are ventilated in NAVA60% for 30min.
Patients return to PS ventilation, according to the Clinical settings as in PScli1 for 30min.